subject: GTOPDB:7995

subject_name: racotumomab

object_name: non-small cell lung carcinoma


subject: UNII:52G405U1E5

tested_intervention: unsure


subject: UMLS:C2986854


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5854395

subject_name: HMBD 001


subject: UMLS:C5854395


subject: UMLS:C5854395


subject: UMLS:C5854395

object_name: pancreatic neoplasm


subject: UMLS:C5854395

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854395

object_name: malignant pancreatic neoplasm


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:6121

subject_name: Ketamine

object_name: anemia

tested_intervention: yes


subject: CHEBI:6121

object_name: Anemia, CTCAE


subject: CHEBI:6121

object_name: pulmonary hypertension


subject: CHEBI:6121

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:6121

object_name: cardiomyopathy


subject: UNII:7R7G6EH5UL

subject_name: Navtemadlin

object_name: acute myeloid leukemia by FAB classification


subject: UNII:7R7G6EH5UL

object_name: acute myeloid leukemia


subject: UNII:7R7G6EH5UL

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: respiratory failure


subject: MESH:D012462

object_name: Respiratory Failure, CTCAE


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: prostate carcinoma


subject: CHEBI:94518

object_name: prostate cancer


subject: CHEBI:6121

object_name: Depression in old age


subject: UMLS:C4764047

subject_name: Recombinant Bovine Basic Fibroblast Growth Factor

object_name: stomatitis


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Drug Interactions


subject: CHEBI:18332

subject_name: Levothyroxine


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:101085

subject_name: Diclofenamide

object_name: hypokalemic periodic paralysis, type 1


subject: CHEBI:101085

object_name: hypokalemic periodic paralysis


subject: CHEBI:101085

object_name: paramyotonia congenita of Von Eulenburg


subject: CHEBI:101085

object_name: hyperkalemic periodic paralysis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Primary Peritoneal Cancer


subject: CHEBI:4026

object_name: Platinum-Resistant Disease


subject: CHEBI:4026

object_name: fallopian tube cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:66964

subject_name: Dronabinol

object_name: thrombocytopenia 1


subject: CHEBI:93775

subject_name: Amethopterin

object_name: CAPN5-related vitreoretinopathy


subject: CHEBI:93775

object_name: proliferative vitreoretinopathy


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:AOH3JC92C0

subject_name: Abexinostat tosylate

object_name: Refractory Breast Carcinoma


subject: UNII:AOH3JC92C0

object_name: Metastatic Breast Carcinoma


subject: UNII:AOH3JC92C0

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: UNII:AOH3JC92C0

object_name: Stage IV Ovarian Carcinoma


subject: UNII:AOH3JC92C0

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:AOH3JC92C0

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:AOH3JC92C0

object_name: Metastatic Fallopian Tube Carcinoma


subject: UNII:AOH3JC92C0

object_name: Locally Advanced Breast Carcinoma


subject: UNII:AOH3JC92C0

object_name: Metastatic endometrioid carcinoma


subject: UNII:AOH3JC92C0

object_name: Metastatic Primary Peritoneal Carcinoma


subject: UNII:AOH3JC92C0

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UNII:AOH3JC92C0

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: UNII:AOH3JC92C0

object_name: Recurrent ovarian cancer


subject: UNII:AOH3JC92C0

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:AOH3JC92C0

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C5205630

object_name: Refractory Breast Carcinoma


subject: UMLS:C5205630

object_name: Metastatic Breast Carcinoma


subject: UMLS:C5205630

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5205630

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: UMLS:C5205630

object_name: Stage IV Ovarian Carcinoma


subject: UMLS:C5205630

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UMLS:C5205630

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5205630

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C5205630

object_name: Metastatic Fallopian Tube Carcinoma


subject: UMLS:C5205630

object_name: Locally Advanced Breast Carcinoma


subject: UMLS:C5205630

object_name: Metastatic endometrioid carcinoma


subject: UMLS:C5205630

object_name: Metastatic Primary Peritoneal Carcinoma


subject: UMLS:C5205630

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C5205630

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5205630

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5205630

object_name: Recurrent ovarian cancer


subject: UMLS:C5205630

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C5205630

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:91951

object_name: Refractory Breast Carcinoma


subject: CHEBI:91951

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:91951

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:91951

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:91951

object_name: Locally Advanced Breast Carcinoma


subject: CHEBI:91951

object_name: Metastatic endometrioid carcinoma


subject: CHEBI:91951

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:91951

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:91951

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant

object_name: Refractory Breast Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IV Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:17756771

object_name: Metastatic Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Locally Advanced Breast Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Metastatic endometrioid carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Metastatic Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Refractory Breast Carcinoma


subject: CHEBI:85993

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:85993

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:85993

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:85993

object_name: Locally Advanced Breast Carcinoma


subject: CHEBI:85993

object_name: Metastatic endometrioid carcinoma


subject: CHEBI:85993

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:85993

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:85993

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:85993

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:52717

subject_name: Bortezomib

object_name: solitary osseous plasmacytoma


subject: CHEBI:52717

object_name: extramedullary plasmacytoma


subject: CHEBI:52717

object_name: light chain deposition disease


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: DS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:2767

object_name: ISS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:2767

object_name: DS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:2767

object_name: ISS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:2767

object_name: ISS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:2767

object_name: DS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: AL amyloidosis


subject: PUBCHEM.COMPOUND:2767

object_name: primary systemic amyloidosis


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: UMLS:C0001641

subject_name: Adrenergic alpha-Antagonists

object_name: benign prostatic hyperplasia


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Adverse effects


subject: CHEBI:31236

object_name: treatment-refractory schizophrenia


subject: CHEBI:31236

object_name: inherited lipid metabolism disorder


subject: CHEBI:31236

object_name: type 2 diabetes mellitus


subject: CHEBI:31236

object_name: Diabetes


subject: CHEBI:31236

object_name: diabetes mellitus


subject: CHEBI:31236

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:82978

subject_name: paliperidone

object_name: psychosis


subject: CHEBI:82978

object_name: Nonorganic psychosis


subject: CHEBI:82978

object_name: Psychosis, CTCAE


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: liver disorder


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: plasmablastic lymphoma


subject: UNII:4Z63YK6E0E

object_name: large-cell immunoblastic lymphoma


subject: UNII:4Z63YK6E0E

object_name: Stage II Diffuse Large B-Cell Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Stage III Diffuse Large B-Cell Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Stage I Diffuse Large B-Cell Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Stage IV Diffuse Large B-Cell Lymphoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:231679

subject_name: ipilimumab

object_name: salivary gland carcinoma


subject: CHEBI:231679

object_name: salivary gland cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:6402

subject_name: Leflunomide

object_name: juvenile idiopathic arthritis


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:89455219

subject_name: tirabrutinib


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: atopic eczema


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Prediabetes


subject: UNII:AHI9T7EDX6

subject_name: Pneumovax 23

object_name: pneumococcal infection


subject: RXCUI:287523


subject: UMLS:C3539963

subject_name: Amide local anesthetic combinations

object_name: respiratory system disorder


subject: UMLS:C3539976

subject_name: Penicillins with extended spectrum combinations


subject: UMLS:C3540719


subject: UMLS:C3539181

subject_name: Short-acting sulfonamide combinations


subject: UMLS:C3540722

subject_name: Beta-lactamase sensitive penicillin combinations


subject: UMLS:C3539959

subject_name: Long-acting sulfonamide combinations


subject: UMLS:C3539969

subject_name: Specific immunoglobulin combinations


subject: UMLS:C3540031

subject_name: gonadotropin combinations


subject: UMLS:C3540026

subject_name: Hepatitis vaccine combinations


subject: UMLS:C3539182

subject_name: Salt solution combinations


subject: UMLS:C3539955

subject_name: lung surfactant combinations


subject: UMLS:C3539956

subject_name: Magnesium antacid compound combinations


subject: UMLS:C3539957

subject_name: opium alkaloids and derivative combination cough suppressants


subject: UMLS:C3539960

subject_name: Other intestinal adsorbent combinations in ATC


subject: UMLS:C3539961

subject_name: Platelet aggregation inhibitor combinations excl. heparin


subject: UMLS:C3539962

subject_name: vitamin D and analog combinations


subject: UMLS:C3539964

subject_name: local opthalmologic anesthetic combinations


subject: UMLS:C3539965

subject_name: Local hemostatic combinations


subject: UMLS:C3539966

subject_name: insulins and analogs for injection combinations, long-acting


subject: UMLS:C3539967

subject_name: Insulins and analogs for injection, intermediate-acting combined with fast-acting- combinations


subject: UMLS:C3539968

subject_name: Enema combinations


subject: UMLS:C3539970

subject_name: combination drugs used in erectile dysfunction


subject: UMLS:C3539971

subject_name: otologic analgesic and anesthetic combinations


subject: UMLS:C3539972

subject_name: Combination solutions for parenteral nutrition


subject: UMLS:C3539973

subject_name: Other antifungal combinations for topical use in ATC


subject: UMLS:C3539974

subject_name: Insulins and analogs for injection, intermediate-acting combinations


subject: UMLS:C3539975

subject_name: Aluminium antacid compound combinations


subject: UMLS:C3539977

subject_name: Calcium antacid compound combinations


subject: UMLS:C3539978

subject_name: expectorant combinations excluding combinations with cough suppressants


subject: UMLS:C3539979

subject_name: Antiinfective irrigating solution combinations


subject: UMLS:C3540027

subject_name: Adrenergic and dopaminergic agents combinations


subject: UMLS:C3540028

subject_name: Other irrigating solution combinations in ATC


subject: UMLS:C3540030

subject_name: other cough suppressant combinations in ATC


subject: UMLS:C3540720

subject_name: Caries prophylactic agent combinations


subject: UMLS:C3540721

subject_name: other nasal preparation combinations in ATC


subject: UMLS:C3540723

subject_name: Insulins and analogs for injection, fast-acting combinations


subject: UMLS:C3540724

subject_name: expectorant combinations, excl. combinations with cough suppressants


subject: UMLS:C3854036

subject_name: Other anti-dementia drug combinations in ATC


subject: CHEBI:49603

subject_name: Lapatinib

object_name: esophageal adenocarcinoma


subject: CHEBI:49603


subject: PUBCHEM.COMPOUND:165437864

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:165437864

object_name: BH4-deficient hyperphenylalaninemia A


subject: UNII:372X2P22UY


subject: UNII:372X2P22UY


subject: CHEBI:49165

object_name: asthma


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: cholelithiasis


subject: UMLS:C0700661

subject_name: Depakene

object_name: Wolfram syndrome


subject: CHEBI:39867

subject_name: Valproic acid


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: bacterial infectious disease


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:9421

subject_name: Tazobactam


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: social phobia


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: cognitive disorder


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Carboplatin adverse reaction


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C1704263

subject_name: green tea extract

object_name: Females


subject: UMLS:C1704263

object_name: sarcopenia


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: UMLS:C3504803

subject_name: Camellia sinensis whole extract


subject: UMLS:C3504803


subject: UMLS:C1443183

subject_name: Camellia sinensis antigen


subject: UMLS:C1443183


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Intravenous Drug Usage


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:83766

subject_name: Olaparib

object_name: Advanced breast cancer


subject: UNII:63WI9S8P1M

subject_name: Tinlarebant

object_name: Geographic atrophy


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Emergence from anesthesia


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: Childhood Breast Carcinoma


subject: CHEBI:4696

object_name: breast carcinoma


subject: CHEBI:4696

object_name: breast cancer


subject: CHEBI:4696


subject: CHEBI:4696

object_name: anxiety disorder


subject: CHEBI:4696

object_name: sleep disorder


subject: CHEBI:4696

object_name: Depressed mood


subject: CHEBI:4696

object_name: Cancer patients and suicide and depression


subject: CHEBI:4696

object_name: Depressed - symptom


subject: CHEBI:4696

object_name: Depression, CTCAE


subject: CHEBI:4696

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:4696

object_name: Fatigue


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499

object_name: cognitive disorder


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: BK-virus nephropathy


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:59729

subject_name: fenfluramine hydrochloride

object_name: developmental and epileptic encephalopathy, 2


subject: CHEBI:59729

object_name: CDKL5 disorder


subject: CHEBI:59729

object_name: Refractory seizures


subject: CHEBI:59729

object_name: Bilateral tonic-clonic seizure


subject: CHEBI:59729

object_name: West syndrome


subject: CHEBI:5000

subject_name: Fenfluramine


subject: CHEBI:5000


subject: CHEBI:5000


subject: CHEBI:5000


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Locally Advanced Cervical Carcinoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Childhood Breast Carcinoma


subject: UMLS:C0003442

object_name: breast carcinoma


subject: UMLS:C0003442

object_name: breast cancer


subject: CHEBI:2668

subject_name: Amlodipine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:2668

object_name: obesity


subject: CHEBI:2668

object_name: Obesity, CTCAE


subject: CHEBI:31547

subject_name: Eplerenone


subject: CHEBI:31547


subject: CHEBI:31547


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: coronary artery disorder


subject: CHEBI:41879

object_name: coronary atherosclerosis


subject: CHEBI:9144

subject_name: Silibinin

object_name: hepatitis C


subject: CHEBI:9144

object_name: HIV infection


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: PUBCHEM.COMPOUND:9837916

subject_name: Sodium naproxen

object_name: Dysmenorrhea, CTCAE


subject: PUBCHEM.COMPOUND:9837916

object_name: Dysmenorrhea


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: complex partial epilepsy


subject: CHEBI:64356

subject_name: Pregabalin


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: chronic kidney disease


subject: MESH:D000077203

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: myelodysplastic syndrome with excess blasts-2


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:91464

object_name: Myelodysplasia


subject: CHEBI:91464

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:91464

object_name: childhood myelodysplastic syndrome


subject: CHEBI:91464

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:91464


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2716103

subject_name: milatuzumab

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2716103

object_name: non-Hodgkin lymphoma


subject: CHEBI:72296

subject_name: Apixaban

object_name: aortic stenosis


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: UMLS:C4528719

object_name: small cell lung carcinoma


subject: UMLS:C4528719

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4528719

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4528719

object_name: sarcoma


subject: UMLS:C4528719

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4528719

object_name: soft tissue sarcoma


subject: UMLS:C4528719

object_name: non-small cell lung carcinoma


subject: UMLS:C4528719

object_name: Adult Solid Neoplasm


subject: UMLS:C5203423

subject_name: Nivolumab Liquid Injection


subject: UMLS:C5203423


subject: UMLS:C5203423


subject: UMLS:C5203423


subject: UMLS:C5203423


subject: UMLS:C5203423


subject: UMLS:C5203423


subject: UMLS:C5203423


subject: CHEBI:23414

subject_name: Cupric sulfate

object_name: type 2 diabetes mellitus


subject: CHEBI:23414

object_name: Diabetes


subject: CHEBI:23414

object_name: diabetes mellitus


subject: CHEBI:23414

object_name: hyperglycemia


subject: CHEBI:23414

object_name: Hyperglycemia, CTCAE


subject: CHEBI:23414

object_name: Glucose in blood specimen above reference range


subject: RXCUI:659877

subject_name: Gardasil

object_name: HPV-related carcinoma


subject: UMLS:C2065042

subject_name: inhaled beclomethasone

object_name: lung transplant infection


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: prostate carcinoma


subject: DRUGBANK:DB14101

object_name: prostate cancer


subject: MESH:C000605453

subject_name: huanglian-jie-du decoction

object_name: Recurrent oral herpes


subject: MESH:C000605453

object_name: Acute pericoronitis


subject: MESH:C000605453

object_name: aphthous stomatitis


subject: UNII:G43E72677U

subject_name: Sodium glycerophosphate

object_name: total parenteral nutrition


subject: CHEBI:125628

subject_name: Alisertib

object_name: myxofibrosarcoma


subject: CHEBI:125628

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: CHEBI:125628

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:125628

object_name: Malignant fibrous histiocytoma recurrent


subject: CHEBI:125628

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: CHEBI:125628

object_name: Liposarcoma recurrent


subject: CHEBI:125628

object_name: Leiomyosarcoma recurrent


subject: CHEBI:125628

object_name: Recurrent Malignant Peripheral Nerve Sheath Tumor


subject: UMLS:C1434448

object_name: Recurrent Malignant Glioma


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: telangiectasis


subject: UNII:ZL1R02VT79

object_name: Telangiectasia, CTCAE 5.0


subject: UNII:ZL1R02VT79

object_name: Cutaneous telangiectasia


subject: UNII:ZL1R02VT79

object_name: Telangiectasia, CTCAE 3.0


subject: UMLS:C1708127

subject_name: GM-K562 Cell Vaccine

object_name: leukemia


subject: UMLS:C1708127

object_name: childhood leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108506

subject_name: INTERFERON ALFA


subject: CHEMBL.COMPOUND:CHEMBL2108506


subject: UMLS:C0043112

subject_name: WELL-FERON


subject: UMLS:C0043112


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C2825023


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: glioblastoma


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection

object_name: no feeling or sensation of skin


subject: UMLS:C5203471

object_name: Sensory Loss


subject: CHEBI:7457

subject_name: Nalmefene


subject: CHEBI:7457


subject: UNII:C3EP7ZZ9UQ

subject_name: TASOCITINIB

object_name: rheumatoid arthritis


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: Compulsion


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: ulcerative colitis


subject: UMLS:C4308782


subject: CHEBI:184662

object_name: Kaposi Sarcoma


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:68845

subject_name: Azilsartan medoxomil

object_name: essential hypertension


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:41423

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:41423

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UNII:43K1W2T1M6


subject: UNII:43K1W2T1M6


subject: PR:000008915

subject_name: interferon alpha-2


subject: PR:000008915


subject: PR:000008915


subject: UMLS:C2937361

subject_name: Interferon alpha 2


subject: UMLS:C2937361


subject: UMLS:C2937361


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: GTOPDB:7748

subject_name: emibetuzumab

object_name: Advanced cancer


subject: GTOPDB:7748

object_name: adult hepatocellular carcinoma


subject: GTOPDB:7748

object_name: liver cancer


subject: GTOPDB:7748

object_name: pediatric hepatocellular carcinoma


subject: GTOPDB:7748

object_name: liver carcinoma


subject: GTOPDB:7748


subject: GTOPDB:7748

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:7748

object_name: clear cell renal carcinoma


subject: GTOPDB:7748

object_name: renal cell adenocarcinoma


subject: GTOPDB:7748

object_name: renal cell carcinoma


subject: GTOPDB:7748

object_name: gastric adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL3301578

subject_name: EMIBETUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: CHEMBL.COMPOUND:CHEMBL3301578


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UNII:GNQ25KYD72

object_name: cognitive disorder


subject: UNII:GNQ25KYD72

object_name: Cognitive impairment


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Sjogren syndrome with other organ involvement


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C2080467

subject_name: Phenobarbital Sodium Liquid Injection

object_name: benign neonatal seizures


subject: CHEBI:8069

subject_name: Phenobarbital


subject: UMLS:C5203425

subject_name: Bumetanide Liquid Injection

object_name: heart failure


subject: UMLS:C5203425

object_name: Heart Failure, CTCAE


subject: CHEBI:41423

object_name: nasopharyngeal carcinoma


subject: CHEBI:41423

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: PUBCHEM.COMPOUND:3370

subject_name: Fludrocortisone acetate

object_name: Hepatic impairment


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:16962

subject_name: Cortisone


subject: PUBCHEM.COMPOUND:135151902

subject_name: OPEVESOSTAT


subject: DRUGBANK:DB18818

subject_name: Opevesostat


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic Carcinoma in the Adrenal Cortex


subject: CHEBI:231614

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:231614

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:V7FWP1D62O

subject_name: NERVE GROWTH FACTOR

object_name: peripheral nervous system disorder


subject: UNII:V7FWP1D62O

object_name: HIV infection


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: PIK3CA Gene Mutation


subject: CHEBI:233362

object_name: Unresectable Solid Neoplasm


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993

object_name: Adult Solid Neoplasm


subject: CHEBI:85993


subject: CHEBI:85993

object_name: Hormone receptor positive tumor


subject: UMLS:C5854429

subject_name: Pan-mutant-selective PI3K-alpha Inhibitor RLY-5836

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854429

object_name: breast carcinoma


subject: UMLS:C5854429

object_name: breast cancer


subject: UMLS:C5854429

object_name: Advanced breast cancer


subject: UMLS:C5854429


subject: UMLS:C5854429


subject: UMLS:C5854429

object_name: Carcinoma breast stage IV


subject: UMLS:C5854429

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5854429


subject: UMLS:C5854429


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C5203431

subject_name: Gemcitabine Liquid Injection


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate


subject: CHEBI:31587


subject: CHEBI:31587


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Chronic cerebrovascular accident


subject: UMLS:C0055108


subject: UMLS:C5556442

subject_name: Clifutinib Besylate

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5556442

object_name: acute myeloid leukemia


subject: UNII:VA46LC5AZQ

object_name: post-traumatic stress disorder


subject: CHEBI:70839

subject_name: Dasatinib

object_name: stage IB pancreatic cancer


subject: CHEBI:70839

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:70839

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:70839

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:70839

object_name: stage IIB pancreatic cancer


subject: CHEBI:70839

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:70839

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:70839

object_name: stage IIA pancreatic cancer


subject: CHEBI:70839

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:70839

object_name: Pancreatic carcinoma stage III


subject: CHEBI:70839

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:70839

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:70839

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:190514

object_name: stage IB pancreatic cancer


subject: CHEBI:190514

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:190514

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:190514

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:190514

object_name: stage IIB pancreatic cancer


subject: CHEBI:190514

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:190514

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:190514

object_name: stage IIA pancreatic cancer


subject: CHEBI:190514

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:190514

object_name: Pancreatic carcinoma stage III


subject: CHEBI:190514

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:190514

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:190514

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:49375

object_name: stage IB pancreatic cancer


subject: CHEBI:49375

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:49375

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:49375

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:49375

object_name: stage IIB pancreatic cancer


subject: CHEBI:49375

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:49375

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:49375

object_name: stage IIA pancreatic cancer


subject: CHEBI:49375

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:49375

object_name: Pancreatic carcinoma stage III


subject: CHEBI:49375

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:49375

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:49375

object_name: pancreatic acinar cell carcinoma


subject: UMLS:C3541937

subject_name: Azadirachta indica whole extract

object_name: Chronic lymphocytic leukaemia stage 2


subject: UMLS:C3541937

object_name: Chronic lymphocytic leukaemia stage 4


subject: UMLS:C3541937

object_name: Chronic lymphocytic leukaemia stage 3


subject: UMLS:C3541937

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: acute myeloid leukemia with multilineage dysplasia


subject: PUBCHEM.COMPOUND:1805

object_name: Blasts 20-30 Percent of Bone Marrow Nucleated Cells


subject: PUBCHEM.COMPOUND:1805

object_name: Blasts 20-30 Percent of Peripheral Blood White Cells


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: Myelodysplasia


subject: CHEBI:231605

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:231605

object_name: childhood myelodysplastic syndrome


subject: CHEBI:231605

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:231605

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:231605


subject: CHEBI:231605


subject: CHEBI:231605


subject: CHEBI:231605

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:231605

object_name: chronic myelomonocytic leukemia


subject: CHEBI:72296

subject_name: Apixaban

object_name: varicose veins


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70752

subject_name: Dabigatran


subject: UNII:12M44VTJ7B

subject_name: DALTEPARIN SODIUM


subject: UMLS:C0498888

subject_name: INJECTION, DALTEPARIN SODIUM, PER 2500 IU ADMINISTERED


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: UNII:3S182ET3UA

subject_name: TINZAPARIN SODIUM


subject: UNII:3S182ET3UA

object_name: venous thromboembolism


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: EXCESS LMW-DNA


subject: UNII:W530IRZ40G

object_name: Blood Clot


subject: UNII:W530IRZ40G

object_name: thrombosis


subject: UNII:W530IRZ40G

object_name: Thrombosis of blood vessel


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:94366


subject: CHEBI:81783

subject_name: Tricyclazole

object_name: non-Hodgkin lymphoma


subject: UMLS:C4521565

subject_name: Beam -- chemical


subject: CHEBI:3423

subject_name: Carmustine


subject: UniProtKB:P0A9E0

subject_name: ARAC_ECOLI Arabinose operon regulatory protein (sprot)


subject: UMLS:C3661049

object_name: Hepatic impairment


subject: CHEBI:134964

subject_name: Perflubutane

object_name: esophagus carcinoma in situ


subject: CHEBI:134964

object_name: benign neoplasm of esophagus


subject: CHEBI:134964

object_name: Esophagus problem


subject: MESH:C069727

subject_name: Sonazoid


subject: MESH:C069727


subject: MESH:C069727


subject: UMLS:C0038818

subject_name: Sunscreening Agents

object_name: Dermatologic Complication


subject: UMLS:C0038818

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: duodenal ulcer


subject: CHEBI:6375

object_name: Duodenal Ulcer, CTCAE


subject: UMLS:C2976285

subject_name: TAK 438


subject: CHEBI:136048

subject_name: Vonoprazan


subject: UMLS:C1440867

subject_name: lactoferrin, bovine


subject: CHEBI:9123

subject_name: Sertraline

object_name: depression anxiety disorder


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:36796

subject_name: duloxetine


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: Prediabetes


subject: CHEBI:71272

object_name: glucose intolerance


subject: CHEBI:71272

object_name: Impaired glucose tolerance


subject: UNII:G2AE2VE07O

subject_name: Revefenacin

object_name: chronic obstructive pulmonary disease


subject: CHEBI:52717

subject_name: Bortezomib

object_name: malignant soft tissue neoplasm


subject: CHEBI:52717

object_name: sarcoma


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: cluster headache syndrome


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Brain Stem Glioblastoma


subject: CHEBI:41774

object_name: glioma susceptibility 1


subject: CHEBI:132106

subject_name: sodium propionate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:132106

object_name: obesity


subject: CHEBI:132106

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: pediatric lymphoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:59877

subject_name: Enalaprilat

object_name: dilated cardiomyopathy


subject: CHEBI:59877

object_name: dilated cardiomyopathy 1A


subject: CHEBI:59877

object_name: hypertension


subject: CHEBI:59877

object_name: Hypertension, CTCAE


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4786


subject: CHEBI:4786


subject: CHEBI:4786


subject: CHEBI:4786


subject: UMLS:C0014027

subject_name: enalaprilat


subject: UMLS:C0014027


subject: UMLS:C0014027


subject: UMLS:C0014027


subject: CHEBI:89324

object_name: irritable bowel syndrome


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842


subject: CHEBI:27300


subject: UMLS:C3537249


subject: UMLS:C1704263

subject_name: green tea extract


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: EXCESS LMW-DNA


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEMBL.COMPOUND:CHEMBL1201458

subject_name: ETHIODIZED OIL

object_name: Metastatic Malignant Neoplasm in the Head and Neck


subject: PUBCHEM.COMPOUND:11199

subject_name: hydroxyethylene


subject: CHEBI:17246

subject_name: Polyvinyl alcohol


subject: MESH:C485817

subject_name: beta-tricalcium phosphate

object_name: Regenerative inflammation


subject: MESH:C485817

object_name: Osteopenia


subject: UMLS:C1328169

object_name: neoplasm


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Non-cystic fibrosis bronchiectasis


subject: UNII:8G388563M7

subject_name: Telotristat ethyl

object_name: neuroendocrine neoplasm


subject: UNII:8G388563M7

object_name: carcinoid syndrome


subject: UNII:8G388563M7

object_name: diarrhea


subject: UNII:8G388563M7

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:8G388563M7

object_name: Diarrhea, CTCAE


subject: CHEBI:49005

subject_name: Deferasirox

object_name: beta thalassemia


subject: CHEBI:49005

object_name: beta-thalassemia HBB/LCRB


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Recurrent Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Grade II Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Grade II Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: grade II meningioma


subject: UNII:2S9ZZM9Q9V

object_name: Atypical Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Atypical Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Grade III Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Grade III Meningioma


subject: UNII:2S9ZZM9Q9V

object_name: grade III meningioma


subject: UNII:2S9ZZM9Q9V

object_name: meningioma


subject: UNII:2S9ZZM9Q9V

object_name: supratentorial meningioma


subject: UNII:2S9ZZM9Q9V

object_name: anaplastic meningioma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Anaplastic (Malignant) Meningioma


subject: UMLS:C3886536

object_name: Geographic atrophy


subject: CHEMBL.COMPOUND:CHEMBL5314371

subject_name: MANGANESE CHLORIDE

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5314371

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5314371

object_name: malignant pancreatic neoplasm


subject: CHEBI:86368

subject_name: LumenHance


subject: CHEBI:86368


subject: CHEBI:86368


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002

object_name: small cell carcinoma


subject: UMLS:C5854501

object_name: small cell lung carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C1971782

subject_name: DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED

object_name: stroke disorder


subject: UMLS:C1971782

object_name: cerebrovascular disorder


subject: UMLS:C1971782

object_name: Stroke (heart beat)


subject: UMLS:C1971782

object_name: Stroke, CTCAE


subject: CHEBI:4469

subject_name: dexamfetamine


subject: CHEBI:4469


subject: CHEBI:4469


subject: CHEBI:4469


subject: CHEMBL.COMPOUND:CHEMBL2108628

subject_name: PACLITAXEL POLIGLUMEX

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: breast cancer


subject: CHEBI:60056

object_name: age-related macular degeneration


subject: CHEBI:27958

subject_name: Cocaine


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Facial Paresis


subject: CHEBI:3160

object_name: Bell's palsy


subject: UMLS:C0684259

subject_name: Humatrope

object_name: osteoporosis


subject: UMLS:C0684259

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C0684259

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C0684259

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C1329986

subject_name: BUPIVACAINE/FENTANYL

object_name: hypertension, pregnancy-induced


subject: CHEBI:32230

subject_name: tiotropium bromide hydrate

object_name: allergic asthma


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: UMLS:C4058555

subject_name: Spiriva Respimat


subject: UMLS:C1957295

object_name: psoriasis


subject: CHEBI:177451

subject_name: Fasiglifam

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:146273261

object_name: rheumatoid arthritis


subject: CHEBI:64019

subject_name: Nebivolol

object_name: Diabetic peripheral neuropathy


subject: CHEBI:63577

subject_name: Lamivudine

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: Status epilepticus


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: esophageal cancer


subject: UMLS:C4086713

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4086713

object_name: neoplasm of esophagus


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Bedwetting


subject: CHEBI:49662

object_name: enuresis


subject: CHEBI:49662

object_name: Urinary incontinence of non-organic origin


subject: CHEBI:49662

object_name: Urinary incontinence


subject: CHEBI:16044

subject_name: L-methionine residue

object_name: type 2 diabetes mellitus


subject: UMLS:C2933414

object_name: non-small cell lung carcinoma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: breast neoplasm


subject: UMLS:C0796512

subject_name: CCI 779


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: influenza


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Uterine carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:6931

subject_name: Midazolam

object_name: Atelectasis


subject: CHEBI:6931

object_name: Ventilator-Induced Lung Injury


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:60791

subject_name: Xylocard

object_name: Airway complication of anaesthesia


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: Childhood Breast Carcinoma


subject: CHEBI:64321

object_name: breast carcinoma


subject: CHEBI:64321

object_name: breast cancer


subject: CHEBI:28834

object_name: neurofibromatosis 1


subject: CHEBI:28834

object_name: neurofibromatosis type 1


subject: CHEBI:28834

object_name: Cutaneous neurofibroma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: peritoneal neoplasm


subject: CHEBI:231601

object_name: gastric neoplasm


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C1879518

subject_name: APO 866

object_name: melanoma


subject: UMLS:C5418039

subject_name: AXL/FLT3/VEGFR2 Inhibitor KC1036

object_name: thymus neoplasm


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: Alveolalgia


subject: UMLS:C0009906

subject_name: Combined Oral Contraceptives

object_name: Other disorders of bone development and growth


subject: PUBCHEM.COMPOUND:131704328

subject_name: Alginic acid

object_name: Barretts esophagus with dysplasia


subject: CHEBI:58187

subject_name: alginate


subject: UMLS:C3273718

subject_name: Maveropepimut-S

object_name: ovarian cancer


subject: UMLS:C3273718

object_name: ovarian neoplasm


subject: UMLS:C3273718

object_name: ovarian carcinoma


subject: UMLS:C3273718

object_name: peritoneum cancer


subject: UMLS:C3273718

object_name: fallopian tube carcinoma


subject: UMLS:C3273718

object_name: fallopian tube cancer


subject: UNII:H2976538CX

subject_name: Dapaconazole

object_name: tinea cruris


subject: GTOPDB:12347

subject_name: penpulimab

object_name: Stomach cancer


subject: GTOPDB:12347

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Ebola hemorrhagic fever


subject: CHEBI:5959

subject_name: Irbesartan


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: leptospirosis


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UMLS:C5555015

subject_name: Rezetamig

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5555015

object_name: non-Hodgkin lymphoma


subject: UMLS:C5706509

subject_name: Anti-CD79b/CD20/CD3 Trispecific Antibody JNJ-80948543


subject: UMLS:C5706509


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: rectum adenocarcinoma


subject: CHEBI:114785

object_name: rectal carcinoma


subject: CHEBI:114785

object_name: rectal cancer


subject: CHEBI:114785

object_name: Childhood Rectal Carcinoma


subject: CHEBI:114785


subject: CHEBI:25187

subject_name: Menthol

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:3367

object_name: AML1-ETO Fusion Protein Expression


subject: CHEBI:63599

subject_name: Fludarabine


subject: PR:000001024

subject_name: neural cell adhesion molecule 1

object_name: adult lymphoma


subject: PR:000001024

object_name: lymphoma


subject: PR:000001024

object_name: pediatric lymphoma


subject: PR:000001024

object_name: acute lymphoblastic leukemia


subject: PR:000001024

object_name: Myelodysplasia


subject: PR:000001024

object_name: acute myeloid leukemia


subject: PR:000001024

object_name: Adult Rhabdomyosarcoma


subject: PR:000001024

object_name: rhabdomyosarcoma


subject: PR:000001024

object_name: Childhood Rhabdomyosarcoma


subject: PR:000001024

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: PR:000001024

object_name: Childhood Neuroblastoma


subject: PR:000001024

object_name: neuroblastoma


subject: UMLS:C0108754

subject_name: CD56 Antigens


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: UMLS:C0108754


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: cauda equina syndrome with neurogenic bladder


subject: CHEBI:100241

object_name: Neurogenic bladder


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:135512673

object_name: coronary atherosclerosis


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: UMLS:C1832002

subject_name: Apoptosis Inducer MPC-2130

object_name: cancer


subject: UMLS:C1832002

object_name: neoplasm


subject: CHEBI:63632

subject_name: Topotecan

object_name: CAPN5-related vitreoretinopathy


subject: CHEBI:63632

object_name: proliferative vitreoretinopathy


subject: CHEBI:63632

object_name: rhegmatogenous retinal detachment


subject: CHEBI:63632

object_name: Proliferative vitreo-retinopathy


subject: UMLS:C4727207

subject_name: Nidanilimab

object_name: biliary tract cancer


subject: UMLS:C4727207

object_name: colorectal cancer


subject: UMLS:C4727207

object_name: colorectal carcinoma


subject: UMLS:C4727207

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4727207

object_name: liver carcinoma


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: acute apical periodontitis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:3219

subject_name: Bupropion

object_name: Childhood Breast Carcinoma


subject: CHEBI:3219

object_name: breast carcinoma


subject: CHEBI:3219

object_name: breast cancer


subject: UNII:L4C1UY2NYH

subject_name: Inavolisib


subject: UNII:L4C1UY2NYH


subject: UNII:L4C1UY2NYH


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: prostate cancer


subject: CHEBI:17290

subject_name: (S)-3-hydroxybutyric acid

object_name: Insulin Sensitivity


subject: CHEBI:17290

object_name: Functional capacity


subject: CHEBI:17290

object_name: Muscle Atrophy


subject: CHEBI:17290

object_name: Lack of sufficient daily physical activity


subject: CHEBI:37054


subject: CHEBI:37054


subject: CHEBI:37054


subject: CHEBI:37054


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C5203179

subject_name: Adalimumab Liquid Injection

object_name: rheumatoid arthritis


subject: UNII:FZ7NYF5N8L

subject_name: IRON SUCROSE

object_name: Iron deficiency


subject: CHEBI:192761

subject_name: Iron sucrose


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: carrier of type B viral hepatitis


subject: CHEBI:7773

subject_name: Ondansetron

object_name: small cell lung carcinoma


subject: UMLS:C5238470

subject_name: Pegylated SN-38 Conjugate PLX038


subject: CHEBI:134689

subject_name: Rucaparib


subject: UMLS:C4045823

object_name: chronic hepatitis C virus infection


subject: CHEBI:74705

subject_name: Met-Leu

object_name: neurotrophic keratopathy


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: liver cancer


subject: UMLS:C0699319

object_name: liver neoplasm


subject: UMLS:C0699319

object_name: Adult Liver Carcinoma


subject: UMLS:C0699319

object_name: nephroblastoma


subject: UMLS:C0699319

object_name: Wilms tumor


subject: UMLS:C0699319

object_name: childhood kidney Wilms tumor


subject: UMLS:C0699319

object_name: rhabdoid tumor


subject: UMLS:C0699319

object_name: yolk sac tumor


subject: UMLS:C0699319

object_name: adult yolk sac tumor


subject: UMLS:C0699319

object_name: testicular yolk sac tumor


subject: UMLS:C0699319

object_name: ovarian yolk sac tumor


subject: UMLS:C0699319

object_name: vaginal yolk sac tumor


subject: UMLS:C0699319

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C0699319

object_name: rhabdomyosarcoma


subject: UMLS:C0699319

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C0699319

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C0699319

object_name: adult liposarcoma


subject: UMLS:C0699319

object_name: liposarcoma


subject: UMLS:C0699319

object_name: pediatric liposarcoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: liver cancer


subject: PUBCHEM.COMPOUND:3368

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: nephroblastoma


subject: PUBCHEM.COMPOUND:3368

object_name: Wilms tumor


subject: PUBCHEM.COMPOUND:3368

object_name: childhood kidney Wilms tumor


subject: PUBCHEM.COMPOUND:3368

object_name: rhabdoid tumor


subject: PUBCHEM.COMPOUND:3368

object_name: yolk sac tumor


subject: PUBCHEM.COMPOUND:3368

object_name: adult yolk sac tumor


subject: PUBCHEM.COMPOUND:3368

object_name: testicular yolk sac tumor


subject: PUBCHEM.COMPOUND:3368

object_name: ovarian yolk sac tumor


subject: PUBCHEM.COMPOUND:3368

object_name: vaginal yolk sac tumor


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: adult liposarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: liposarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: pediatric liposarcoma


subject: UMLS:C0700805

object_name: liver cancer


subject: UMLS:C0700805

object_name: liver neoplasm


subject: UMLS:C0700805

object_name: Adult Liver Carcinoma


subject: UMLS:C0700805

object_name: liver carcinoma


subject: UMLS:C0700805

object_name: nephroblastoma


subject: UMLS:C0700805

object_name: Wilms tumor


subject: UMLS:C0700805

object_name: childhood kidney Wilms tumor


subject: UMLS:C0700805

object_name: rhabdoid tumor


subject: UMLS:C0700805

object_name: yolk sac tumor


subject: UMLS:C0700805

object_name: adult yolk sac tumor


subject: UMLS:C0700805

object_name: testicular yolk sac tumor


subject: UMLS:C0700805

object_name: ovarian yolk sac tumor


subject: UMLS:C0700805

object_name: vaginal yolk sac tumor


subject: UMLS:C0700805

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C0700805

object_name: rhabdomyosarcoma


subject: UMLS:C0700805

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C0700805

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C0700805

object_name: adult liposarcoma


subject: UMLS:C0700805

object_name: liposarcoma


subject: UMLS:C0700805

object_name: pediatric liposarcoma


subject: CHEBI:63599

subject_name: Fludarabine

object_name: liver cancer


subject: CHEBI:63599

object_name: liver neoplasm


subject: CHEBI:63599

object_name: Adult Liver Carcinoma


subject: CHEBI:63599

object_name: nephroblastoma


subject: CHEBI:63599

object_name: Wilms tumor


subject: CHEBI:63599

object_name: childhood kidney Wilms tumor


subject: CHEBI:63599

object_name: rhabdoid tumor


subject: CHEBI:63599

object_name: yolk sac tumor


subject: CHEBI:63599

object_name: adult yolk sac tumor


subject: CHEBI:63599

object_name: testicular yolk sac tumor


subject: CHEBI:63599

object_name: ovarian yolk sac tumor


subject: CHEBI:63599

object_name: vaginal yolk sac tumor


subject: CHEBI:63599

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:63599

object_name: rhabdomyosarcoma


subject: CHEBI:63599

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:63599

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:63599

object_name: adult liposarcoma


subject: CHEBI:63599

object_name: liposarcoma


subject: CHEBI:63599

object_name: pediatric liposarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297826

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL4297826

object_name: acute myeloid leukemia


subject: UMLS:C4329311

subject_name: Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A


subject: UMLS:C4329311


subject: UMLS:C5203831

subject_name: Iodine I 124 Monoclonal Antibody M5A

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C5203831

object_name: Colorectal Carcinoma Metastatic in the Liver


subject: UMLS:C5203831

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UMLS:C5203831

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UMLS:C5203831

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UMLS:C5203831

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UMLS:C1870424

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1870424

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:67271

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:67271

object_name: endometrium adenocarcinoma


subject: CHEBI:67271

object_name: endometrial serous adenocarcinoma


subject: CHEBI:67271

object_name: endometrial adenosquamous carcinoma


subject: CHEBI:176724

subject_name: Etiracetam

object_name: self-limited epilepsy with centrotemporal spikes


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:94782

subject_name: Cediranib

object_name: non-small cell lung carcinoma


subject: CHEBI:231342

subject_name: ceralasertib


subject: GTOPDB:13607

subject_name: danvatirsen


subject: UNII:31N550RD05

subject_name: Danvatirsen


subject: UMLS:C4287766


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Nasal congestion


subject: CHEBI:41879

object_name: Nasopharyngeal obstruction


subject: CHEBI:41879

object_name: Snoring


subject: CHEBI:41879

object_name: ear infection


subject: PUBCHEM.COMPOUND:124091099

object_name: breast neoplasm


subject: UNII:62GM7VW6AO


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: prostate carcinoma


subject: UMLS:C5444737

object_name: prostate cancer


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: DRUGBANK:DB10708


subject: UMLS:C5417912

subject_name: MEK 1/2 Inhibitor FCN-159

object_name: neurofibromatosis 1


subject: UMLS:C5417912

object_name: neurofibromatosis type 1


subject: UMLS:C5417912

object_name: plexiform neurofibroma


subject: CHEBI:7565

subject_name: Nifedipine

object_name: preterm premature rupture of the membranes


subject: PUBCHEM.COMPOUND:51059404

subject_name: Blisibimod

object_name: EXCESS LMW-DNA


subject: UNII:114VP6C6ES

subject_name: BLISIBIMOD


subject: UMLS:C3713826


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Cervical intraepithelial neoplasia grade 1


subject: CHEBI:49868


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: skin neoplasm


subject: UNII:1C6V77QF41

object_name: skin cancer


subject: UNII:1C6V77QF41

object_name: healthy, no evidence of disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C0718234

subject_name: Acthar

object_name: focal segmental glomerulosclerosis


subject: UMLS:C0718234

object_name: Focal Segmental Glomerulosclerosis, Not Otherwise Specified


subject: CHEBI:42068

subject_name: Idarubicin

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:42068

object_name: myoclonic dystonia 11


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Myelodysplasia


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib


subject: CHEBI:85164


subject: CHEBI:74947

subject_name: Thalidomide

object_name: syringomyelia


subject: CHEBI:74947

object_name: Syringomyelia and syringobulbia


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:141969

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:141969

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:141969

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Breast cancer recurrent


subject: CHEBI:141969

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:141969

object_name: Carcinoma breast stage IV


subject: CHEBI:141969

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:141969

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: outcomes general quality of life


subject: CHEBI:5855

object_name: Perceived quality of life


subject: CHEBI:5855

object_name: Good quality of life


subject: UMLS:C1513016

subject_name: Matrix Metalloproteinase Inhibitors

object_name: lichen planus, oral


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: influenza


subject: DRUGBANK:DB17293

object_name: Severe Acute Respiratory Distress Syndrome


subject: DRUGBANK:DB17293

object_name: smallpox


subject: DRUGBANK:DB17293

object_name: Ebola hemorrhagic fever


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UMLS:C2826358

object_name: non-small cell lung carcinoma


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Late onset asthma


subject: CHEBI:84363

object_name: hepatitis C


subject: CHEBI:84363

object_name: chronic hepatitis C virus infection


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: CHEBI:36796

subject_name: duloxetine

object_name: peripheral nervous system disorder


subject: CHEBI:36796

object_name: neuropathy


subject: CHEBI:36796

object_name: HIV infection


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: CHEBI:167309


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Bradycardia


subject: UNII:C8ADC441ME

object_name: systolic heart failure


subject: UNII:C8ADC441ME

object_name: diastolic heart failure


subject: UNII:C8ADC441ME

object_name: Non-ischaemic cardiomyopathy


subject: UNII:C8ADC441ME

object_name: ischemic cardiomyopathy


subject: CHEBI:6904

subject_name: Metoprolol

object_name: heart failure


subject: CHEBI:6904

object_name: Heart Failure, CTCAE


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: myeloid leukemia


subject: UNII:43K1W2T1M6

object_name: Myelodysplasia


subject: CHEBI:77590

subject_name: Armodafinil

object_name: hypersomnia


subject: PUBCHEM.COMPOUND:134517711

subject_name: soquelitinib

object_name: atopic eczema


subject: UNII:6I5H17AN3I

subject_name: SOQUELITINIB


subject: CHEBI:31654

subject_name: gliclazide

object_name: Diabetes


subject: CHEBI:31654

object_name: diabetes mellitus


subject: CHEBI:201471

subject_name: Prochloraz Metabolite BTS 40348


subject: CHEBI:201471


subject: PR:000005930

subject_name: macrophage colony-stimulating factor 1

object_name: presbyopia


subject: UMLS:C0079784

subject_name: Macrophage Colony-Stimulating Factor


subject: CHEBI:90863

subject_name: Sonidegib

object_name: Basal Cell Cancer


subject: CHEBI:90863

object_name: eyelid neoplasm


subject: CHEBI:182803

subject_name: Porfiromycine

object_name: head and neck neoplasm


subject: CHEBI:208611

subject_name: Porfiromycin


subject: UNII:Z1AVZ44TEJ

subject_name: Ebopiprant

object_name: Premature Labor


subject: UNII:1487U1Q3IQ

subject_name: ELSUBRUTINIB

object_name: rheumatoid arthritis


subject: DRUGBANK:DB18850

subject_name: Elsubrutinib


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Cooley's anemia


subject: CHEBI:66919

object_name: beta thalassemia


subject: PR:000015920

subject_name: prostatic spermine-binding protein

object_name: Blood Pressure Finding


subject: PR:000015920

object_name: Systemic arterial pressure


subject: PR:000015920

object_name: aneurysm


subject: PR:000015920

object_name: Cognitive impairment


subject: PR:000015920

object_name: Ischemic stroke


subject: PR:000014836

subject_name: sex hormone-binding globulin


subject: PR:000014836


subject: PR:000014836


subject: PR:000014836


subject: PR:000014836


subject: PR:000014606

subject_name: methanethiol oxidase


subject: PR:000014606


subject: PR:000014606


subject: PR:000014606


subject: PR:000014606


subject: PR:000023914

subject_name: sulfate-binding protein


subject: PR:000023914


subject: PR:000023914


subject: PR:000023914


subject: PR:000023914


subject: UniProtKB:P0AG78

subject_name: SUBI_ECOLI Sulfate-binding protein (sprot)


subject: UniProtKB:P0AG78


subject: UniProtKB:P0AG78


subject: UniProtKB:P0AG78


subject: UniProtKB:P0AG78


subject: UniProtKB:P08723

subject_name: SPBP_RAT Prostatic spermine-binding protein (sprot)


subject: UniProtKB:P08723


subject: UniProtKB:P08723


subject: UniProtKB:P08723


subject: UniProtKB:P08723


subject: PUBCHEM.COMPOUND:147740

subject_name: Yasmin

object_name: endometriosis


subject: UMLS:C0939533


subject: UMLS:C5418061

object_name: Light chain (AL) amyloidosis


subject: UMLS:C4287697

object_name: clear cell sarcoma


subject: UMLS:C4085967

subject_name: Oleclumab

object_name: triple-negative breast carcinoma


subject: UMLS:C4085967

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0885240

subject_name: mother of pearl homeopathic preparation

object_name: postmenopausal osteoporosis


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: prostate cancer


subject: CHEBI:173077


subject: CHEBI:173077


subject: MESH:C000608433

object_name: chronic hepatitis B virus infection


subject: CHEBI:3175

subject_name: Brimonidine

object_name: Disorder of intraocular pressure


subject: CHEBI:3175

object_name: Intraocular Pressure


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:9757

subject_name: Tropicamide


subject: CHEBI:9757


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: biliary tract cancer


subject: GTOPDB:13396

object_name: liver carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: PUBCHEM.COMPOUND:32874

subject_name: Adriblastin

object_name: mantle cell lymphoma


subject: UMLS:C2936928


subject: CHEBI:28830

subject_name: Chlorambucil


subject: UMLS:C0591063

subject_name: Alkeran


subject: CHEBI:49668

subject_name: Gefitinib

object_name: squamous cell carcinoma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: C-kit gene mutation


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C2349000

subject_name: Human Papillomavirus Vaccine V503

object_name: Genital warts


subject: UMLS:C2349000

object_name: anus neoplasm


subject: UMLS:C1541153

subject_name: TOCOSOL™ Paclitaxel

object_name: breast neoplasm


subject: UMLS:C5785763

subject_name: ALDH1/3 Inhibitor ABD-3001

object_name: Myelodysplasia


subject: UMLS:C5785763

object_name: adult acute myeloid leukemia


subject: CHEBI:6432

subject_name: Levamisole

object_name: hemoglobinuria


subject: CHEBI:6432

object_name: Hemoglobinuria, CTCAE 5.0


subject: CHEBI:6432

object_name: Hemoglobinuria, CTCAE 3.0


subject: CHEBI:6432

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:6432

object_name: hemolytic anemia


subject: CHEBI:6432

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:6432

object_name: aplastic anemia


subject: CHEBI:6432

object_name: idiopathic aplastic anemia


subject: CHEBI:6432

object_name: proteinuria


subject: CHEBI:6432

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:6432

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:6432

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:6432

object_name: Bone marrow depression


subject: CHEBI:6432

object_name: pancytopenia


subject: CHEBI:6432

object_name: Bone marrow hypocellularity


subject: CHEBI:6432

object_name: Urination Disorders


subject: CHEBI:6432

object_name: Blood Clot


subject: CHEBI:6432

object_name: thrombosis


subject: CHEBI:6432

object_name: Thrombosis of blood vessel


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: hemoglobinuria


subject: CHEBI:201431

object_name: Hemoglobinuria, CTCAE 5.0


subject: CHEBI:201431

object_name: Hemoglobinuria, CTCAE 3.0


subject: CHEBI:201431

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:201431

object_name: hemolytic anemia


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease


subject: UMLS:C3540778


subject: UMLS:C3540778


subject: UMLS:C3540778


subject: UMLS:C3540778


subject: UMLS:C3540778

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C3540778

object_name: aplastic anemia


subject: UMLS:C3540778

object_name: idiopathic aplastic anemia


subject: UMLS:C3540778

object_name: proteinuria


subject: UMLS:C3540778

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C3540778

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C3540778

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C3540778

object_name: Bone marrow depression


subject: UMLS:C3540778

object_name: pancytopenia


subject: UMLS:C3540778

object_name: Bone marrow hypocellularity


subject: UMLS:C3540778

object_name: Urination Disorders


subject: UMLS:C3540778

object_name: Blood Clot


subject: UMLS:C3540778

object_name: thrombosis


subject: UMLS:C3540778

object_name: Thrombosis of blood vessel


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: hemoglobinuria


subject: CHEBI:24261

object_name: Hemoglobinuria, CTCAE 5.0


subject: CHEBI:24261

object_name: Hemoglobinuria, CTCAE 3.0


subject: CHEBI:24261

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:24261

object_name: hemolytic anemia


subject: CHEBI:24261

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:24261

object_name: aplastic anemia


subject: CHEBI:24261

object_name: idiopathic aplastic anemia


subject: CHEBI:24261

object_name: proteinuria


subject: CHEBI:24261

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:24261

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:24261

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:24261

object_name: Bone marrow depression


subject: CHEBI:24261

object_name: pancytopenia


subject: CHEBI:24261

object_name: Bone marrow hypocellularity


subject: CHEBI:24261

object_name: Urination Disorders


subject: CHEBI:24261

object_name: Blood Clot


subject: CHEBI:24261

object_name: thrombosis


subject: CHEBI:24261

object_name: Thrombosis of blood vessel


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic

object_name: hemoglobinuria


subject: UMLS:C3540777

object_name: Hemoglobinuria, CTCAE 5.0


subject: UMLS:C3540777

object_name: Hemoglobinuria, CTCAE 3.0


subject: UMLS:C3540777

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C3540777

object_name: hemolytic anemia


subject: UMLS:C3540777

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C3540777

object_name: aplastic anemia


subject: UMLS:C3540777

object_name: idiopathic aplastic anemia


subject: UMLS:C3540777

object_name: proteinuria


subject: UMLS:C3540777

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C3540777

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C3540777

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C3540777

object_name: Bone marrow depression


subject: UMLS:C3540777

object_name: pancytopenia


subject: UMLS:C3540777

object_name: Bone marrow hypocellularity


subject: UMLS:C3540777

object_name: Urination Disorders


subject: UMLS:C3540777

object_name: Blood Clot


subject: UMLS:C3540777

object_name: thrombosis


subject: UMLS:C3540777

object_name: Thrombosis of blood vessel


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Albuminuria


subject: CHEBI:601027

object_name: Macroalbuminuric nephropathy due to diabetes mellitus


subject: CHEBI:601027

object_name: Moderate albuminuria


subject: CHEBI:601027

object_name: Diabetes


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: GTOPDB:4985


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: type 1 diabetes mellitus


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:94534

subject_name: olanzapine

object_name: Childhood Breast Carcinoma


subject: CHEBI:94534

object_name: breast carcinoma


subject: CHEBI:94534

object_name: breast cancer


subject: CHEBI:231679

subject_name: ipilimumab

object_name: prostate disorder


subject: CHEBI:231679

object_name: prostate neoplasm


subject: CHEBI:231679

object_name: male reproductive system neoplasm


subject: CHEBI:231679

object_name: male reproductive organ cancer


subject: CHEBI:231679

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UniProtKB:P0ABJ9

subject_name: CYDA_ECOLI Cytochrome bd-I ubiquinol oxidase subunit 1 (sprot)

object_name: dengue disease


subject: UniProtKB:P0ABJ9

object_name: Severe Dengue


subject: PR:000022361

subject_name: cytochrome bd-I ubiquinol oxidase subunit 1


subject: PR:000022361


subject: CHEBI:22586

subject_name: antioxidant

object_name: Liver Fibrosis


subject: UMLS:C0003402

subject_name: Antioxidants


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:9144

subject_name: Silibinin


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:6888

object_name: aplastic anemia


subject: CHEBI:6888

object_name: idiopathic aplastic anemia


subject: CHEBI:6888

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:6888

object_name: childhood myelodysplastic syndrome


subject: CHEBI:6888

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:6888

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:6888

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: Myelodysplasia


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:L63605PZ70

subject_name: TALAPORFIN SODIUM

object_name: Metastatic malignant neoplasm to liver


subject: UNII:L63605PZ70

object_name: Neoplasm Metastasis


subject: UNII:L63605PZ70

object_name: colorectal neoplasm


subject: UNII:L63605PZ70

object_name: liver neoplasm


subject: UMLS:C1312955

subject_name: talaporfin sodium


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: CHEBI:135875

subject_name: Talaporfin


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: DRUGBANK:DB05918


subject: DRUGBANK:DB05918


subject: DRUGBANK:DB05918


subject: DRUGBANK:DB05918


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: inborn mitochondrial myopathy


subject: CHEBI:16737

subject_name: Creatinine

object_name: Chagas' disease (chronic) with other organ involvement


subject: CHEBI:63633

subject_name: Triptorelin

object_name: hypogonadism


subject: CHEBI:63633

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:63633

object_name: metabolic syndrome X


subject: CHEBI:63633

object_name: Fatty Liver


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: oral cavity squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: oropharynx squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:4875

subject_name: Etanercept

object_name: lupus nephritis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEMBL.COMPOUND:CHEMBL1237024

subject_name: SIPULEUCEL-T

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: intracerebral hemorrhage


subject: CHEBI:60799

subject_name: Esketamine

object_name: Dyssomnias


subject: CHEBI:60799

object_name: Sleep abnormality


subject: CHEBI:60799

object_name: sleep disorder


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: peritoneum cancer


subject: UMLS:C3640818


subject: CHEBI:231614

subject_name: Nivolumab

object_name: leiomyosarcoma


subject: CHEBI:231614

object_name: Childhood Leiomyosarcoma


subject: CHEBI:231614

object_name: Adult Leiomyosarcoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Inoperable Disease


subject: CHEBI:175901

object_name: Localized Pancreatic Adenocarcinoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C5446585

subject_name: Emidurdar


subject: UMLS:C5446585

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C5446585


subject: UMLS:C5446585

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: heart disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:7983

subject_name: Pentobarbital


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: Acne inversa


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: non-small cell squamous lung carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: CHEBI:63620

subject_name: Rasagiline

object_name: multiple system atrophy


subject: CHEBI:231416

subject_name: Danicopan


subject: UMLS:C3489662

object_name: heart failure


subject: UMLS:C3489662

object_name: Heart Failure, CTCAE


subject: UMLS:C0042210

subject_name: Vaccines

object_name: diphtheria


subject: UMLS:C0042210

object_name: tetanus


subject: UMLS:C0042210

object_name: poliomyelitis


subject: UMLS:C0042210

object_name: pertussis


subject: UMLS:C0042210

object_name: Whooping cough


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C0879373

subject_name: Iodinated Contrast Agent

object_name: breast carcinoma


subject: UMLS:C0879373

object_name: invasive breast carcinoma


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: Refractory Plasmablastic Lymphoma


subject: UNII:DB1041CXDG

object_name: ALK-positive large B-cell lymphoma


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol


subject: PUBCHEM.COMPOUND:5466794

object_name: Gastric Mixed Adenocarcinoma


subject: PUBCHEM.COMPOUND:5466794

object_name: diffuse gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:5466794

object_name: gastric intestinal type adenocarcinoma


subject: PUBCHEM.COMPOUND:5466794

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: Malignant neoplasm of stomach stage IV


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IIIB Gastric Carcinoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IIIA Gastric Carcinoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: GTOPDB:9615

object_name: triple-negative breast carcinoma


subject: GTOPDB:9615


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C4722367


subject: UMLS:C4722367


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: UMLS:C4758796


subject: UMLS:C4758796


subject: UNII:FIJ3OLQ3N8


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C2826130


subject: UMLS:C4722124


subject: UMLS:C4722124


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: PUBCHEM.COMPOUND:9831414


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C5777124


subject: UMLS:C4552849

subject_name: haNK


subject: UMLS:C4552849


subject: UMLS:C4733699

subject_name: cafusertib hydrochloride

object_name: neoplasm


subject: PUBCHEM.COMPOUND:21982135

object_name: Fractured rib


subject: CHEBI:73038

subject_name: Parecoxib


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Shock


subject: UNII:T42P99266K

object_name: acute kidney failure


subject: UNII:T42P99266K

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:50733

subject_name: nutraceutical

object_name: end stage renal failure


subject: CHEBI:50733

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Acute Stroke Related to COVID-19


subject: UMLS:C0678113

subject_name: Actilyse

object_name: Acute Stroke


subject: UMLS:C0678113


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Physical trauma


subject: CHEBI:35475

object_name: Injury


subject: CHEBI:35475

object_name: Trauma


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: UMLS:C0358845


subject: UMLS:C0358845


subject: UMLS:C0021741

subject_name: Actimmune

object_name: hepatitis C